Opioid settlement reached with four drug companies: report
In this article:
Four drug companies reached a settlement for their role in the opioid crisis. Yahoo Finance's Anjalee Khemlani joined On The Move to discuss
Advertisement
Recommended Stories
A Once-in-a-Decade Opportunity: 3 Magnificent Dividend Stocks Down Between 19% and 28% to Buy Now and Hold Forever
These three low-volatility, dividend-growth stocks offer the potential to rebound while trading near decade-low valuations.
Motley FoolAre Stocks Going to Crash? This Forecasting Tool Hasn't Been Wrong in 65 Years, and It Has a Sobering Message for Wall Street
This historically flawless predictive tool has accurately foreshadowed what's to come for the U.S. economy since 1959.
Motley FoolUtility stocks are on fire — here are Wall Street analysts' top picks
Utility stocks are outperforming the broader markets. Here's a look at three top picks from analysts.
Yahoo FinanceFort Worth's tallest building sells for just $12.3M at auction in stunning price drop
The tallest building in Fort Worth, Texas, has been bought by a bank for $12.3 million, three years after it sold $137.5 million. Burnett Plaza has 40 stories and is 567 feet tall.
Fox BusinessFact or Fiction: Congress Stole From Social Security and Should Return the Money It's Taken, With Interest
Did lawmakers really pilfer Social Security's piggy bank? Here's the truth.
Motley FoolQuantumScape Making Big Moves: Time to Buy Before It Skyrockets?
The battery start-up might reach its ambitions sooner than expected.
Motley FoolPalantir Increased Its Guidance, but Investors Are Selling. Is It Time to Buy the Stock?
Why did the stock sink after its Q1 earnings report?
Motley FoolShould You Buy Nvidia Stock Before May 22?
Nvidia is scheduled to make a significant investor announcement that could have enormous implications for the stock price.
Motley FoolI’m 67 with $25,000 saved for retirement, but I just got a big pay raise. Should I claim Social Security now while I’m still working?
“I don’t have a financial adviser because no one‘s going to take $25,000.”
MarketWatchUPDATE 3-Billionaire quant investing pioneer and philanthropist James Simons dies at 86
Billionaire investor James Simons, the mathematician and Cold War code-breaker who founded one of the world's most prominent and profitable hedge funds, Renaissance Technologies, has died at 86, his foundation said on Friday. The Simons Foundation did not give a cause of death. Sixty years ago Simons -- who preferred to be known as Jim -- shifted course from teaching mathematics and working in U.S. intelligence to investing.
Reuters